Recurrent Heart Failure From Fulminant Giant Cell Myocarditis Following COVID-19 Infection Requiring Heart

Alan Amedi1, Jay N Patel2, Zachary Brennan1

  • 1Department of Cardiac Surgery, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.

JACC. Case Reports
|August 15, 2025
PubMed

Insights

Giant cell myocarditis (GCM) is a rare, aggressive heart condition. Early diagnosis and treatment, including mechanical support, are crucial for improving outcomes in patients with this severe form of myocarditis.

Area of Science:

  • Cardiology
  • Immunology
  • Pathology

Background:

  • Giant cell myocarditis (GCM) is a rare, rapidly progressive inflammatory cardiomyopathy.
  • Characterized by T cell-mediated myocardial destruction, GCM presents diagnostic challenges and poor outcomes without prompt intervention.

Observation:

  • A 46-year-old woman with recent COVID-19 developed flulike symptoms and dyspnea, rapidly progressing to cardiogenic shock.
  • Mechanical circulatory support with venoarterial extracorporeal membrane oxygenation was initiated.
  • Endomyocardial biopsy confirmed fulminant necrotizing myocarditis, leading to immunosuppressive therapy.

Findings:

  • Despite initial treatment and discharge, the patient experienced recurrent shock, necessitating reinitiation of mechanical support.
  • Orthotopic heart transplantation was ultimately performed.
  • Explanted heart pathology definitively diagnosed Giant Cell Myocarditis.

Implications:

  • GCM can mimic other myocarditis presentations, highlighting the necessity of endomyocardial biopsy for accurate diagnosis.
  • This case emphasizes the potential for a fulminant clinical course in GCM.
  • Early recognition, aggressive immunosuppression, and timely mechanical support are vital for managing GCM.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
22
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
16
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
33
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
48
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
41
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
30